Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients. / Jensen, P E H; Sellebjerg, F; Søndergaard, H B; Sørensen, P S.

I: European Journal of Neurology, Bind 19, Nr. 10, 2012, s. 1311-7.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Jensen, PEH, Sellebjerg, F, Søndergaard, HB & Sørensen, PS 2012, 'Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients', European Journal of Neurology, bind 19, nr. 10, s. 1311-7. https://doi.org/10.1111/j.1468-1331.2012.03721.x

APA

Jensen, P. E. H., Sellebjerg, F., Søndergaard, H. B., & Sørensen, P. S. (2012). Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients. European Journal of Neurology, 19(10), 1311-7. https://doi.org/10.1111/j.1468-1331.2012.03721.x

Vancouver

Jensen PEH, Sellebjerg F, Søndergaard HB, Sørensen PS. Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients. European Journal of Neurology. 2012;19(10):1311-7. https://doi.org/10.1111/j.1468-1331.2012.03721.x

Author

Jensen, P E H ; Sellebjerg, F ; Søndergaard, H B ; Sørensen, P S. / Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients. I: European Journal of Neurology. 2012 ; Bind 19, Nr. 10. s. 1311-7.

Bibtex

@article{3fd061f91e454331bdf6cafff4f4db65,
title = "Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients",
abstract = "Measurements of binding antibodies (BAbs), neutralizing antibodies (NAbs) and MX1 mRNA expression are used to analyse the immunological reactions in patients with MS treated with IFN-β. The correlations between these are yet not fully understood.",
author = "Jensen, {P E H} and F Sellebjerg and S{\o}ndergaard, {H B} and S{\o}rensen, {P S}",
note = "{\textcopyright} 2012 The Author(s) European Journal of Neurology {\textcopyright} 2012 EFNS.",
year = "2012",
doi = "10.1111/j.1468-1331.2012.03721.x",
language = "English",
volume = "19",
pages = "1311--7",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell",
number = "10",

}

RIS

TY - JOUR

T1 - Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients

AU - Jensen, P E H

AU - Sellebjerg, F

AU - Søndergaard, H B

AU - Sørensen, P S

N1 - © 2012 The Author(s) European Journal of Neurology © 2012 EFNS.

PY - 2012

Y1 - 2012

N2 - Measurements of binding antibodies (BAbs), neutralizing antibodies (NAbs) and MX1 mRNA expression are used to analyse the immunological reactions in patients with MS treated with IFN-β. The correlations between these are yet not fully understood.

AB - Measurements of binding antibodies (BAbs), neutralizing antibodies (NAbs) and MX1 mRNA expression are used to analyse the immunological reactions in patients with MS treated with IFN-β. The correlations between these are yet not fully understood.

U2 - 10.1111/j.1468-1331.2012.03721.x

DO - 10.1111/j.1468-1331.2012.03721.x

M3 - Journal article

C2 - 22564111

VL - 19

SP - 1311

EP - 1317

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 10

ER -

ID: 48569339